City

Houston (1)

Irving (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

ABM Therapeutics Corporation (1)

Masonic Cancer Center, University of Minnesota (1)

Collaborator

Intervention

abm-168 (1)

busulfan (1)

fludarabine (1)

levetiracetam (1)

melphalan (1)

rituximab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

nf1 mutation

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Solid Tumor, RAS Mutation, RAF Mutation Trial in Houston, Irving (ABM-168)

Recruiting

Advanced Solid Tumor
+3 more

ABM-168

Houston, Texas
+1 more

Apr 14, 2023

Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

Not yet recruiting

Hematologic Malignancy
+21 more

Fludarabine
+4 more

(no location specified)

Feb 9, 2023